Clinical liver disease文章索引

期刊名：Clinical liver disease

缩写：

ISSN：2046-2484

e-ISSN：

IF/分区：0.0/

共收录本刊相关文章索引1260条

Approach to immunotherapy for HCC in the liver transplant population [0.03%] 肝移植人群肝癌免疫治疗的方法学探究

Peter D Block,Mario Strazzabosco,Ariel Jaffe Peter D Block

Review Clinical liver disease. 2024 May 3;23(1):e0158. DOI:10.1097/CLD.0000000000000158 2024

HBV elimination in Africa-Current status and challenges [0.03%] 非洲乙肝消除现状及挑战

Mark W Sonderup,C Wendy Spearman Mark W Sonderup

Review Clinical liver disease. 2024 May 3;23(1):e0166. DOI:10.1097/CLD.0000000000000166 2024

Role of artificial intelligence in the management of chronic hepatitis B infection [0.03%] 人工智能在慢性乙型肝炎管理中的作用

Tung-Hung Su,Jia-Horng Kao Tung-Hung Su

Review Clinical liver disease. 2024 May 3;23(1):e0164. DOI:10.1097/CLD.0000000000000164 2024

Finite therapy of chronic hepatitis B infection: Pros [0.03%] 慢性乙型肝炎感染的有限期治疗：优势分析

Margarita Papatheodoridi,George Papatheodoridis Margarita Papatheodoridi

Review Clinical liver disease. 2024 May 3;23(1):e0148. DOI:10.1097/CLD.0000000000000148 2024

Finite therapy of chronic hepatitis B infection: Cons [0.03%] 慢性乙型肝炎感染的有限期治疗：反对意见

Yao-Chun Hsu Yao-Chun Hsu

Review Clinical liver disease. 2024 May 3;23(1):e0146. DOI:10.1097/CLD.0000000000000146 2024

A history of the treatment of primary liver cancer [0.03%] 原发性肝癌的治疗历程

Jordi Bruix Jordi Bruix

Review Clinical liver disease. 2024 May 3;23(1):e0147. DOI:10.1097/CLD.0000000000000147 2024

Novel biomarkers and strategies for HCC diagnosis and care [0.03%] 新型生物标志物和肝癌诊断与治疗策略

Allison E Wang,Emily A Leven,Lauren T Grinspan et al. Allison E Wang et al.

Review Clinical liver disease. 2024 May 3;23(1):e0152. DOI:10.1097/CLD.0000000000000152 2024

How to achieve a functional cure for chronic hepatitis B infection [0.03%] 如何实现慢性乙型肝炎感染的功能性治愈

Wen-Juei Jeng,Anna S Lok Wen-Juei Jeng

Review Clinical liver disease. 2024 Apr 26;23(1):e0134. DOI:10.1097/CLD.0000000000000134 2024

The pharmacology of exercise: Strategies and challenges in the optimization of functional status in cirrhosis [0.03%] 运动药理学：优化肝硬化患者功能状态的策略和挑战

Alan Noll,Raha Sadjadi Alan Noll

Review Clinical liver disease. 2024 Apr 26;23(1):e0165. DOI:10.1097/CLD.0000000000000165 2024

History of the liver-heart relationship [0.03%] 肝心关系史研究

Samuel S Lee,Jing Zhang,Annie Yan Chen et al. Samuel S Lee et al.

Review Clinical liver disease. 2024 Apr 26;23(1):e0151. DOI:10.1097/CLD.0000000000000151 2024